These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 19542620)

  • 1. The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited.
    Taylor DH; Østbye T; Langa KM; Weir D; Plassman BL
    J Alzheimers Dis; 2009; 17(4):807-15. PubMed ID: 19542620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Medicare Claims Data as a Tool to Identify Dementia.
    Lee E; Gatz M; Tseng C; Schneider LS; Pawluczyk S; Wu AH; Deapen D
    J Alzheimers Dis; 2019; 67(2):769-778. PubMed ID: 30689589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misidentification of Dementia in Medicare Claims and Related Costs.
    Zhu CW; Ornstein KA; Cosentino S; Gu Y; Andrews H; Stern Y
    J Am Geriatr Soc; 2019 Feb; 67(2):269-276. PubMed ID: 30315744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records.
    Newcomer R; Clay T; Luxenberg JS; Miller RH
    J Am Geriatr Soc; 1999 Feb; 47(2):215-9. PubMed ID: 9988293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Real-World Medicare Costs of Alzheimer Disease: Considerations for Policy and Care.
    Pyenson B; Sawhney TG; Steffens C; Rotter D; Peschin S; Scott J; Jenkins E
    J Manag Care Spec Pharm; 2019 Jul; 25(7):800-809. PubMed ID: 31232206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Dementia in Recent Medicare Claims Data, Compared With Rigorous Clinical Assessments.
    Grodstein F; Chang CH; Capuano AW; Power MC; Marquez DX; Barnes LL; Bennett DA; James BD; Bynum JPW
    J Gerontol A Biol Sci Med Sci; 2022 Jun; 77(6):1272-1278. PubMed ID: 34919685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.
    Brown ML; Riley GF; Potosky AL; Etzioni RD
    Med Care; 1999 Dec; 37(12):1249-59. PubMed ID: 10599606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Discretionary decisions in claims data analyses and their effects - an explorative comparison using the example of a cost of illness study on dementia].
    Schwarzkopf L; Menn P; Holle R
    Gesundheitswesen; 2012 Aug; 74(8-9):e76-83. PubMed ID: 22932829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of the Use of Algorithmic Diagnoses or Medicare Claims to Ascertain Dementia.
    Power MC; Gianattasio KZ; Ciarleglio A
    Neuroepidemiology; 2020; 54(6):462-471. PubMed ID: 33075766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of Alzheimer's disease and related dementia in managed-medicare.
    Gutterman EM; Markowitz JS; Lewis B; Fillit H
    J Am Geriatr Soc; 1999 Sep; 47(9):1065-71. PubMed ID: 10484247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How much do persons with Alzheimer's disease cost Medicare?
    Taylor DH; Sloan FA
    J Am Geriatr Soc; 2000 Jun; 48(6):639-46. PubMed ID: 10855599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of dementia diagnoses and cognitive function measures in Medicare claims and the Minimum Data Set.
    Niznik JD; Lund JL; Hanson LC; Colón-Emeric C; Kelley CJ; Gilliam M; Thorpe CT
    J Am Geriatr Soc; 2024 Aug; 72(8):2381-2390. PubMed ID: 38814274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical and economic burden of newly diagnosed Alzheimer's disease in a medicare advantage population.
    Suehs BT; Davis CD; Alvir J; van Amerongen D; Pharmd NC; Joshi AV; Faison WE; Shah SN
    Am J Alzheimers Dis Other Demen; 2013 Jun; 28(4):384-92. PubMed ID: 23687180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of otolaryngology claims to Medicare in 2012.
    Bhattacharyya N; Lin HW
    Otolaryngol Head Neck Surg; 2014 Nov; 151(5):802-4. PubMed ID: 25085322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The accuracy of medicare claims data in identifying Alzheimer's disease.
    Taylor DH; Fillenbaum GG; Ezell ME
    J Clin Epidemiol; 2002 Sep; 55(9):929-37. PubMed ID: 12393082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attributable Cost of Dementia: Demonstrating Pitfalls of Ignoring Multiple Health Care System Utilization.
    Lei L; Cooley SG; Phibbs CS; Kinosian B; Allman RM; Porsteinsson AP; Intrator O
    Health Serv Res; 2018 Dec; 53 Suppl 3(Suppl Suppl 3):5331-5351. PubMed ID: 30246404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer.
    Onukwugha E; Yong C; Hussain A; Seal B; Mullins CD
    BMC Med Res Methodol; 2014 Jan; 14():1. PubMed ID: 24383436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excess costs of dementia disorders and the role of age and gender - an analysis of German health and long-term care insurance claims data.
    Schwarzkopf L; Menn P; Leidl R; Wunder S; Mehlig H; Marx P; Graessel E; Holle R
    BMC Health Serv Res; 2012 Jun; 12():165. PubMed ID: 22713212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health Care Utilization and Cost Outcomes of a Comprehensive Dementia Care Program for Medicare Beneficiaries.
    Jennings LA; Laffan AM; Schlissel AC; Colligan E; Tan Z; Wenger NS; Reuben DB
    JAMA Intern Med; 2019 Feb; 179(2):161-166. PubMed ID: 30575846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monetary costs of dementia in the United States.
    Hurd MD; Martorell P; Delavande A; Mullen KJ; Langa KM
    N Engl J Med; 2013 Apr; 368(14):1326-34. PubMed ID: 23550670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.